Modern approaches to the diagnosis and treatment of patients with non-muscle-invasive bladder cancer

Abstract

The review article discusses modern methods for diagnosing and treating patients with non-muscle-invasive bladder cancer. The search and analysis of information was carried out in the databases PubMed, Google Scholar, eLibrary. Information about photodynamic diagnostics, narrow-band imaging, mono- and bipolar transurethral resection, transurethral thulium and holmium laser resection, en-bloc resection of neoplasms, Nd:YAG laser ablation of the tumor bed is presented. The features, advantages and disadvantages of each of these methods, as well as their combinations and modifications are described in detail. Particular attention is paid to the use of laser technologies in the surgical treatment of patients with non-muscle-invasive bladder cancer. An analysis of the results of studies of the efficacy and safety of various methods of surgical treatment of non-muscle-invasive bladder cancer was carried out. The significance of the problem of increasing the efficiency of treatment of such patients, which is one of the priority areas of modern oncourology, is indicated.

Keywords

non-muscle-invasive bladder cancer / transurethral resection / en-bloc resection / laser resection / thulium laser / holmium laser / neodymium laser / Tm:YAG laser / Ho:YAG laser / Nd:YAG laser

References

[1] Weijers Y, Arentsen HC, Arends TJ, Witjes JA. Management of low-risk and intermediate-risk non-muscle-invasive bladder carcinoma. Hematol Oncol Clin North Am. 2015;29(2):219–225. DOI: 10.1016/j.hoc.2014.11.001

[2] Weijers Y., Arentsen H.C., Arends T.J., Witjes J.A. Management of low-risk and intermediate-risk non-muscle-invasive bladder carcinoma // Hematol Oncol Clin North Am. 2015. Vol. 29, No. 2. P. 219–225. DOI: 10.1016/j.hoc.2014.11.001

[3] Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–387. DOI: 10.1016/j.ejca.2018.07.005

[4] Ferlay J., Colombet M., Soerjomataram I., et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018 // Eur J Cancer. 2018. Vol. 103. P. 356–387. DOI: 10.1016/j.ejca.2018.07.005

[5] Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN2012. Int J Cancer. 2015;136(5):E359–E386. DOI: 10.1002/ijc.29210

[6] Ferlay J., Soerjomataram I., Dikshit R., et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN2012 // Int J Cancer. 2015. Vol. 136, No. 5. P. E359–E386. DOI: 10.1002/ijc.29210

[7] Kaprin AD, Starinskii VV, Shakhzadova AO. Zlokachestvennye novoobrazovaniya v Rossii v 2021 godu (zabolevaemost’ i smertnost’). Moscow: FGBU “MNIOI im. P.A. Gertsena” Minzdrava Rossii, 2022. 252 p. (In Russ.)

[8] Каприн А.Д., Старинский В.В., Шахзадова А.О. Злокачественные новообразования в России в 2021 году (заболеваемость и смертность). Москва: МНИОИ им. П.А. Герцена, 2022. 252 с.

[9] Chavan S, Bray F, Lortet-Tieulent J, et al. International variations in bladder cancer incidence and mortality. Eur Urol. 2014;66(1):59–73. DOI: 10.1016/j.eururo.2013.10.001

[10] Chavan S., Bray F., Lortet-Tieulent J., et al. International variations in bladder cancer incidence and mortality // Eur Urol. 2014. Vol. 66, No. 1. P. 59–73. DOI: 10.1016/j.eururo.2013.10.001

[11] Moyer VA. Screening for bladder cancer: U.S. Preventive Services task force recommendation statement. Ann Intern Med. 2011;155(4): 246–251. DOI: 10.7326/0003-4819-155-4-201108160-00008

[12] Moyer V.A. Screening for bladder cancer: U.S. Preventive Services task force recommendation statement // Ann Intern Med. 2011. Vol. 155, No. 4. P. 246–251. DOI: 10.7326/0003-4819-155-4-201108160-00008

[13] Burger M, Catto JWF, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63(2):234–241. DOI: 10.1016/j.eururo.2012.07.033

[14] Burger M., Catto J.W.F., Dalbagni G., et al. Epidemiology and risk factors of urothelial bladder cancer // Eur Urol. 2013. Vol. 63, No. 2. P. 234–241. DOI: 10.1016/j.eururo.2012.07.033

[15] Calderone C, Taylor JM. Urothelial cancer of the bladder: treatment of early stage disease. Abdominal Key. 2017;157:24.

[16] Calderone C., Taylor J.M. Urothelial cancer of the bladder: treatment of early stage disease // Abdominal Key. 2017. Vol. 157. ID 24.

[17] Ploeg M, Aben KK, Hulsbergen-van de Kaa CA, et al. Clinical epidemiology of nonurothelial bladder cancer: analysis of the Netherlands Cancer Registry. J Urol. 2010;183(3):915–920. DOI: 10.1016/j.juro.2009.11.018

[18] Ploeg M., Aben K.K., Hulsbergen-van de Kaa C.A., et al. Clinical epidemiology of nonurothelial bladder cancer: analysis of the Netherlands Cancer Registry // J Urol. 2010. Vol. 183, No. 3. P. 915–920. DOI: 10.1016/j.juro.2009.11.018

[19] Ramirez D, Gupta A, Canter D, et al. Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer. BJU Int. 2016;117(5):783–786. DOI: 10.1111/bju.13345

[20] Ramirez D., Gupta A., Canter D., et al. Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer // BJU Int. 2016. Vol. 117, No. 5. P. 783–786. DOI: 10.1111/bju.13345

[21] Yafi FA, Brimo F, Steinberg J, et al. Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urol Oncol. 2015;33(2):66.e25–66e.31. DOI: 10.1016/j.urolonc.2014.06.008

[22] Yafi F.A., Brimo F., Steinberg J., et al. Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer // Urol Oncol. 2015. Vol. 33, No. 2. P. 66.e25–66e.31. DOI: 10.1016/j.urolonc.2014.06.008

[23] Krajewski W, Kościelska-Kasprzak K, Rymaszewska J, Zdrojowy R. How different cystoscopy methods influence patient sexual satisfaction, anxiety, and depression levels: a randomized prospective trial. Qual Life Res. 2017;26(3):625–634. DOI: 10.1007/s11136-016-1493-1

[24] Krajewski W., Kościelska-Kasprzak K., Rymaszewska J., Zdrojowy R. How different cystoscopy methods influence patient sexual satisfaction, anxiety, and depression levels: a randomized prospective trial // Qual Life Res. 2017. Vol. 26, No. 3. P. 625–634. DOI: 10.1007/s11136-016-1493-1

[25] DeGeorge KC, Holt HR, Hodges SC. Bladder cancer: Diagnosis and treatment. Am Fam Physician. 2017;96(8):507–514.

[26] DeGeorge K.C., Holt H.R., Hodges S.C. Bladder cancer: Diagnosis and treatment // Am Fam Physician. 2017. Vol. 96, No. 8. P. 507–514.

[27] Choyke PL. Radiologic evaluation of hematuria: guidelines from the American College of Radiology’s appropriateness criteria. Am Fam Physician. 2008;78(3):347–352.

[28] Choyke P.L. Radiologic evaluation of hematuria: guidelines from the American College of Radiology’s appropriateness criteria // Am Fam Physician. 2008. Vol. 78, No. 3. P. 347–352.

[29] Huang L, Kong Q, Liu Z, et al. The diagnostic value of MR imaging in differentiating T staging of bladder cancer: A meta-analysis. Radiology. 2018;286(2):502–511. DOI: 10.1148/radiol.2017171028

[30] Huang L., Kong Q., Liu Z., et al. The diagnostic value of MR imaging in differentiating T staging of bladder cancer: A meta-analysis // Radiology. 2018. Vol. 286, No. 2. P. 502–511. DOI: 10.1148/radiol.2017171028

[31] Palou J, Rodríguez-Rubio F, Huguet J, et al. Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor. J Urol. 2005;174(3):859–861. DOI: 10.1097/01.ju.0000169424.79702.6d

[32] Palou J., Rodríguez-Rubio F., Huguet J., et al. Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor // J Urol. 2005. Vol. 174, No. 3. P. 859–861. DOI: 10.1097/01.ju.0000169424.79702.6d

[33] Vind-Kezunovic S, Bouchelouche K, Ipsen P, et al. Detection of lymph node metastasis in patients with bladder cancer using maximum standardised uptake value and 18f-fluorodeoxyglucose positron emission tomography/computed tomography: Results from a high-volume centre including long-term follow-up. Eur Urol Focus. 2019;5(1):90–96. DOI: 10.1016/j.euf.2017.06.005

[34] Vind-Kezunovic S., Bouchelouche K., Ipsen P., et al. Detection of lymph node metastasis in patients with bladder cancer using maximum standardised uptake value and 18f-fluorodeoxyglucose positron emission tomography/computed tomography: Results from a high-volume centre including long-term follow-up // Eur Urol Focus. 2019. Vol. 5, No. 1. P. 90–96. DOI: 10.1016/j.euf.2017.06.005

[35] Palou J, Pisano F, Sylvester R, et al. Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought. World J Urol. 2018;36(10):1621–1627. DOI: 10.1007/s00345-018-2299-2

[36] Palou J., Pisano F., Sylvester R., et al. Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought // World J Urol. 2018. Vol. 36, No. 10. P. 1621–1627. DOI: 10.1007/s00345-018-2299-2

[37] Burger M, Grossman HB, Droller M, et al. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur Urol. 2013;64(5):846–854. DOI: 10.1016/j.eururo.2013.03.059

[38] Burger M., Grossman H.B., Droller M., et al. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data // Eur Urol. 2013. Vol. 64, No. 5. P. 846–854. DOI: 10.1016/j.eururo.2013.03.059

[39] Jocham D, Witjes F, Wagner S, et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol. 2005;174(3):862–866. DOI: 10.1097/01.ju.0000169257.19841.2a

[40] Jocham D., Witjes F., Wagner S., et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study // J Urol. 2005. Vol. 174, No. 3. P. 862–866. DOI: 10.1097/01.ju.0000169257.19841.2a

[41] Stenzl A, Burger M, Fradet Y, et al. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. J Urol. 2010;184(5):1907–1913. DOI: 10.1016/j.juro.2010.06.148

[42] Stenzl A., Burger M., Fradet Y., et al. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer // J Urol. 2010. Vol. 184, No. 5. P. 1907–1913. DOI: 10.1016/j.juro.2010.06.148

[43] Hermann GG, Mogensen K, Carlsson S, et al. Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study. BJU Int. 2011;108(8b): E297–E303. DOI: 10.1111/j.1464-410X.2011.10090.x

[44] Hermann G.G., Mogensen K., Carlsson S., et al. Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study // BJU Int. 2011. Vol. 108, No. 8b. P. E297–E303. DOI: 10.1111/j.1464-410X.2011.10090.x

[45] Li K, Lin T, Fan X, et al. Diagnosis of narrow-band imaging in non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Int J Urol. 2013;20(6):602–609. DOI: 10.1111/j.1442-2042.2012.03211.x

[46] Li K., Lin T., Fan X., et al. Diagnosis of narrow-band imaging in non-muscle-invasive bladder cancer: a systematic review and meta-analysis // Int J Urol. 2013. Vol. 20, No. 6. P. 602–609. DOI: 10.1111/j.1442-2042.2012.03211.x

[47] Venkatramani V, Panda A, Manojkumar R, Kekre NS. Monopolar versus bipolar transurethral resection of bladder tumors: a single center, parallel arm, randomized, controlled trial. J Urol. 2014;191(6):1703–1707. DOI: 10.1016/j.juro.2013.12.004

[48] Venkatramani V., Panda A., Manojkumar R., Kekre N.S. Monopolar versus bipolar transurethral resection of bladder tumors: a single center, parallel arm, randomized, controlled trial // J Urol. 2014. Vol. 191, No. 6. P. 1703–1707. DOI: 10.1016/j.juro.2013.12.004

[49] Wang DS, Bird VG, Leonard VY, et al. Use of bipolar energy for transurethral resection of bladder tumors: pathologic considerations. J Endourol. 2004;18(6):578–582. DOI: 10.1089/end.2004.18.578

[50] Wang D.S., Bird V.G., Leonard V.Y., et al. Use of bipolar energy for transurethral resection of bladder tumors: pathologic considerations // J Endourol. 2004. Vol. 18, No. 6. P. 578–582. DOI: 10.1089/end.2004.18.578

[51] Zhao C, Tang K, Yang H, et al. Bipolar versus monopolar transurethral resection of nonmuscle-invasive bladder cancer: A meta-analysis. J Endourol. 2016;30(1):5–12. DOI: 10.1089/end.2015.0410

[52] Zhao C., Tang K., Yang H., et al. Bipolar versus monopolar transurethral resection of nonmuscle-invasive bladder cancer: A meta-analysis // J Endourol. 2016. Vol. 30, No. 1. P. 5–12. DOI: 10.1089/end.2015.0410

[53] Pradhan M, Gnyawali D. MP49–13 safety and efficacy of monopolar vs bipolar transurethral resection of bladder tumor. J Urol. 2020;203(S4): e746–e746. DOI: 10.1097/JU.0000000000000911.013

[54] Pradhan M., Gnyawali D. MP49-13 safety and efficacy of monopolar vs bipolar transurethral resection of bladder tumor // J Urol. 2020. Vol. 203, No. S4. P. e746–e746. DOI: 10.1097/JU.0000000000000911.013

[55] Ukai R, Kawashita E, Ikeda H. A new technique for transurethral resection of superficial bladder tumor in 1 piece. J Urol. 2000;163(3):878–879. DOI: 10.1016/S0022-5347(05)67824-X

[56] Ukai R., Kawashita E., Ikeda H. A new technique for transurethral resection of superficial bladder tumor in 1 piece // J Urol. 2000. Vol. 163, No. 3. P. 878–879. DOI: 10.1016/S0022-5347(05)67824-X

[57] Naselli A, Puppo P. En Bloc Transurethral resection of bladder tumors: A new standard? J Endourol. 2017;31(S1):S20–S24. DOI: 10.1089/end.2016.0534

[58] Naselli A., Puppo P. En Bloc Transurethral resection of bladder tumors: A new standard? // J Endourol. 2017. Vol. 31, No. S1. P. S20–S24. DOI: 10.1089/end.2016.0534

[59] Grimberg DC, Shah A, Inman BA. En bloc resection of bladder tumors: Style or substance? Eur Urol. 2020;78(4):570–571. DOI: 10.1016/j.eururo.2020.05.019

[60] Grimberg D.C., Shah A., Inman B.A. En bloc resection of bladder tumors: Style or substance? // Eur Urol. 2020. Vol. 78, No. 4. P. 570–571. DOI: 10.1016/j.eururo.2020.05.019

[61] Wu Y-P, Lin T-T, Chen S-H, et al. Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: A meta-analysis. Medicine (Baltimore). 2016;95(45):e5372. DOI: 10.1097/MD.0000000000005372

[62] Wu Y.-P., Lin T.-T., Chen S.-H., et al. Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: A meta-analysis // Medicine (Baltimore). 2016. Vol. 95, No. 45. ID e5372. DOI: 10.1097/MD.0000000000005372

[63] Sureka SK, Agarwal V, Agnihotri S, et al. Is en-bloc transurethral resection of bladder tumor for non-muscle invasive bladder carcinoma better than conventional technique in terms of recurrence and progression? A prospective study. Indian J Urol. 2014;30(2):144–149. DOI: 10.4103/0970-1591.126887

[64] Sureka S.K., Agarwal V., Agnihotri S., et al. Is en-bloc transurethral resection of bladder tumor for non-muscle invasive bladder carcinoma better than conventional technique in terms of recurrence and progression? A prospective study // Indian J Urol. 2014. Vol. 30, No. 2. P. 144–149. DOI: 10.4103/0970-1591.126887

[65] Kislyakov DA, Severgina LO, Tsarichenko DG, et al. Novel approaches for transurethral en-bloc resection of large bladder tumors. Urologiia. 2019;(4):105–111. (In Russ.) DOI: 10.18565/urology.2019.4.105-111

[66] Кисляков Д.А., Севергина Л.О., Цариченко Д.Г., и др. Новые подходы к методике трансуретрального удаления опухолей мочевого пузыря большого размера единым блоком // Урология. 2019. № 4. С. 105–111. DOI: 10.18565/urology.2019.4.105-111

[67] Enikeev D, Shariat SF. Novel technologies that change the diagnostic and treatment paradigm in urology: En-bloc as the new treatment standard. Curr Opin Urol. 2020;30(3):475–476. DOI: 10.1097/mou.0000000000000747

[68] Enikeev D., Shariat S.F. Novel technologies that change the diagnostic and treatment paradigm in urology: En-bloc as the new treatment standard // Curr Opin Urol. 2020. Vol. 30, No. 3. P. 475–476. DOI: 10.1097/mou.0000000000000747

[69] Kamalov AA, Sorokin NI, Dymov AM, et al. Technical aspects of laser en bloc resection of the bladder tumor for non-muscle-invasive bladder cancer. Surgical practice. 2020;(1):53–58. (In Russ.) DOI: 10.38181/2223-2427-2020-1-53-58

[70] Камалов А.А., Сорокин Н.И., Дымов А.М., и др. Технические аспекты лазерной en bloc резекции стенки мочевого пузыря с опухолью при мышечно-неинвазивном раке мочевого пузыря // Хирургическая практика. 2020. № 1. С. 53–58. DOI: 10.38181/2223-2427-2020-1-53-58

[71] Laukhtina EA, Shpikina AD, Taratkin MS, et al. The efficacy and safety of EN BLOC resection in non-muscle-invasive bladder cancer. Urology and Andrology. 2020;8(1): 26–39. (In Russ.) DOI: 10.20953/2307-6631-2020-1-26-39

[72] Лаухтина Е.А., Шпикина А.Д., Тараткин М.С., и др. Эффективность и безопасность EN BLOC резекции при мышечно-неинвазивном раке мочевого пузыря // Вопросы урологии и андрологии. 2020. Т. 8, № 1. С. 26–39. DOI: 10.20953/2307-6631-2020-1-26-39

[73] Sorokin NI, Enikeev DV, Dymov AM, et al. Safety and efficacy of thulium transurethral en block resection with fiber laser “Urоlaz” for treatment of non-muscle-invasive bladder cancer. Cancer Urology. 2018;14(1): 144–151. (In Russ.) DOI: 10.17650/1726-9776-2018-14-1-144-151

[74] Сорокин Н.И., Еникеев Д.В., Дымов А.М., и др. Эффективность и безопасность резекции стенки мочевого пузыря с опухолью единым блоком с использованием тулиевого волоконного лазера «Уролаз» // Онкоурология. 2018. Т. 14, № 1. С. 144–151. DOI: 10.17650/1726-9776-2018-14-1-144-151

[75] Enikeev D, Babjuk M, Shpikina A, et al. En bloc resection for nonmuscle-invasive bladder cancer: selecting a proper laser. Curr Opin Urol. 2022;32(2):173–178. DOI: 10.1097/MOU.0000000000000968

[76] Enikeev D., Babjuk M., Shpikina A., et al. En bloc resection for nonmuscle-invasive bladder cancer: selecting a proper laser // Curr Opin Urol. 2022. Vol. 32, No. 2. P. 173–178. DOI: 10.1097/MOU.0000000000000968

[77] Cho Y-H, Chi S-C, Hernanadez AD, et al. Adriamycin absorption after Nd: YAG laser coagulation compared to electrosurgical resection of the bladder wall. J Urol. 1992;147(4):1139–1141. DOI: 10.1016/s0022-5347(17)37503-1

[78] Cho Y.-H., Chi S.-C., Hernanadez A.D., et al. Adriamycin absorption after Nd: YAG laser coagulation compared to electrosurgical resection of the bladder wall // J Urol. 1992. Vol. 147, No. 4. P. 1139–1141. DOI: 10.1016/s0022-5347(17)37503-1

[79] Bai Y, Liu L, Yuan H, et al. Safety and efficacy of transurethral laser therapy for bladder cancer: a systematic review and meta-analysis. World J Surg Oncol. 2014;12:301. DOI: 10.1186/1477-7819-12-301

[80] Bai Y., Liu L., Yuan H., et al. Safety and efficacy of transurethral laser therapy for bladder cancer: a systematic review and meta-analysis // World J Surg Oncol. 2014. Vol. 12. ID 301. DOI: 10.1186/1477-7819-12-301

[81] Yang H, Wang N, Han S, et al. Comparison of the efficacy and feasibility of laser enucleation of bladder tumor versus transurethral resection of bladder tumor: a meta-analysis. Lasers Med Sci. 2017;32(9):2005–2012. DOI: 10.1007/s10103-017-2308-5

[82] Yang H., Wang N., Han S., et al. Comparison of the efficacy and feasibility of laser enucleation of bladder tumor versus transurethral resection of bladder tumor: a meta-analysis // Lasers Med Sci. 2017. Vol. 32, No. 9. P. 2005–2012. DOI: 10.1007/s10103-017-2308-5

[83] Wang W, Liu H, Xia S. Thulium laser treatment for bladder cancer. Asian J Urol. 2016;3(3):130–133. DOI: 10.1016/j.ajur.2016.05.002

[84] Wang W., Liu H., Xia S. Thulium laser treatment for bladder cancer // Asian J Urol. 2016. Vol. 3, No. 3. P. 130–133. DOI: 10.1016/j.ajur.2016.05.002

[85] Herrmann TR, Liatsikos EN, Nagele U, et al. EAU guidelines on laser technologies. Eur Urol. 2012;61(4):783–795. DOI: 10.1016/j.eururo.2012.01.010

[86] Herrmann T.R., Liatsikos E.N., Nagele U., et al. EAU guidelines on laser technologies // Eur Urol. 2012. Vol. 61, No. 4. P. 783–795. DOI: 10.1016/j.eururo.2012.01.010

[87] Gao X, Ren S, Xu C, Sun Y. Thulium laser resection via a flexible cystoscope for recurrent non-muscle-invasive bladder cancer: initial clinical experience. BJU Int. 2008;102(9):1115–1118. DOI: 10.1111/j.1464-410X.2008.07814.x

[88] Gao X., Ren S., Xu C., Sun Y. Thulium laser resection via a flexible cystoscope for recurrent non-muscle-invasive bladder cancer: initial clinical experience // BJU Int. 2008. Vol. 102, No. 9. P. 1115–1118. DOI: 10.1111/j.1464-410X.2008.07814.x

[89] Wolters M, Kramer MW, Becker JU, et al. Tm: YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience. World J Urol. 2011;29(4):429–432. DOI: 10.1007/s00345-011-0686-z

[90] Wolters M., Kramer M.W., Becker J.U., et al. Tm: YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience // World J Urol. 2011. Vol. 29, No. 4. P. 429–432. DOI: 10.1007/s00345-011-0686-z

[91] Kuntz RM. Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol. 2006;49(6):961–969. DOI: 10.1016/j.eururo.2006.03.028

[92] Kuntz R.M. Current role of lasers in the treatment of benign prostatic hyperplasia (BPH) // Eur Urol. 2006. Vol. 49, No. 6. P. 961–969. DOI: 10.1016/j.eururo.2006.03.028

[93] Koca O, Keleş MO, Kaya C, et al. Plasmakinetic vaporization versus transurethral resection of the prostate: Six-year results. Turk J Urol. 2014;40(3):134–137. DOI: 10.5152/tud.2014.82195

[94] Koca O., Keleş M.O., Kaya C., et al. Plasmakinetic vaporization versus transurethral resection of the prostate: Six-year results // Turk J Urol. 2014. Vol. 40, No. 3. P. 134–137. DOI: 10.5152/tud.2014.82195

[95] Iscaife A, Ribeiro Filho LA, Aparecido Pereira MWA, et al. Holmium laser resection of large bladder tumors: Technique description, feasibility, and histopathological quality analysis. Urology. 2022;165:373. DOI: 10.1016/j.urology.2022.04.021

[96] Iscaife A., Ribeiro Filho L.A., Aparecido Pereira M.W.A., et al. Holmium laser resection of large bladder tumors: Technique description, feasibility, and histopathological quality analysis // Urology. 2022. Vol. 165. P. 373. DOI: 10.1016/j.urology.2022.04.021

[97] Gupta NP, Saini AK, Dogra PN, et al. Bipolar energy for transurethral resection of bladder tumours at low-power settings: initial experience. BJU Int. 2011;108(4):553–556. DOI: 10.1111/j.1464-410X.2010.09903.x

[98] Gupta N.P., Saini A.K., Dogra P.N., et al. Bipolar energy for transurethral resection of bladder tumours at low-power settings: initial experience // BJU Int. 2011. Vol. 108, No. 4. P. 553–556. DOI: 10.1111/j.1464-410X.2010.09903.x

[99] Gravas S, Bachmann A, Reich O, et al. Critical review of lasers in benign prostatic hyperplasia (BPH). BJU Int. 2011;107(7):1030–1043. DOI: 10.1111/j.1464-410X.2010.09954.x

[100] Gravas S., Bachmann A., Reich O., et al. Critical review of lasers in benign prostatic hyperplasia (BPH) // BJU Int. 2011. Vol. 107, No. 7. P. 1030–1043. DOI: 10.1111/j.1464-410X.2010.09954.x

[101] Chen C-H, Chiang P-H, Chuang Y-C, et al. Preliminary results of prostate vaporization in the treatment of benign prostatic hyperplasia by using a 200-W high-intensity diode laser. Urology. 2010;75(3):658–663. DOI: 10.1016/j.urology.2009.09.033

[102] Chen C.-H., Chiang P.-H., Chuang Y.-C., et al. Preliminary results of prostate vaporization in the treatment of benign prostatic hyperplasia by using a 200-W high-intensity diode laser // Urology. 2010. Vol. 75, No. 3. P. 658–663. DOI: 10.1016/j.urology.2009.09.033

[103] Teichmann H-O, Herrmann TR, Bach T. Technical aspects of lasers in urology. World J Urol. 2007;25(3):221–225. DOI: 10.1007/s00345-007-0184-5

[104] Teichmann H.-O., Herrmann T.R., Bach T. Technical aspects of lasers in urology // World J Urol. 2007. Vol. 25, No. 3. P. 221–225. DOI: 10.1007/s00345-007-0184-5

[105] Rasshupkina EV, Teodorovich OV, Kochiev DG, et al. Experimental validation of ND: YAG laser coagulation of the bladder tissue. Urologiia. 2015;(3):55–59. (In Russ.)

[106] Расщупкина Е.В., Теодорович О.В., Кочиев Д.Г., и др. Экспериментальное обоснование использования ND: YAG-лазерной коагуляции ткани мочевого пузыря // Урология. 2015. № 3. С. 55–59.

[107] Borota AV, Konopko AV, Anishchenko AA, et al. Sposoby khirurgicheskogo lecheniya invazivnogo raka mochevogo puzyrya (obzor literatury). Novoobrazovanie. 2010;(2):24–35. (In Russ.)

[108] Борота А.В., Конопко А.В., Анищенко А.А., и др. Способы хирургического лечения инвазивного рака мочевого пузыря (обзор литературы) // Новообразование. 2010. № 2. С. 24–35.

[109] Dołowy Ł, Krajewski W, Dembowski J, et al. The role of lasers in modern urology. Cent European J Urol. 2015;68(2):175–182. DOI: 10.5173/ceju.2015.53

[110] Dołowy Ł., Krajewski W., Dembowski J., et al. The role of lasers in modern urology // Cent European J Urol. 2015. Vol. 68, No. 2. P. 175–182. DOI: 10.5173/ceju.2015.53

[111] Heinrich E, Wendt-Nordahl G, Honeck P, et al. 120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. J Endourol. 2010;24(1):75–79. DOI: 10.1089/end.2009.0051

[112] Heinrich E., Wendt-Nordahl G., Honeck P., et al. 120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model // J Endourol. 2010. Vol. 24, No. 1. P. 75–79. DOI: 10.1089/end.2009.0051

[113] Teodorovich OV, Shatokhin MN, Abdullaev MI, et al. Interstitial laser coagulation in the management of urothelial papillary carcinoma of the renal pelvis. Urologiia. 2018;(4):122–126. (In Russ.) DOI: 10.18565/urology.2018.4.122-126

[114] Теодорович О.В., Шатохин М.Н., Абдуллаев М.И., и др. Интерстициальная лазерная коагуляция в лечении уротелиального папиллярного рака лоханки // Урология. 2018. № 4. C. 122–126. DOI: 10.18565/urology.2018.4.122-126

RIGHTS & PERMISSIONS

Eco-Vector